Results 71 to 80 of about 5,659 (219)
Patients with hypertrophic cardiomyopathy had significantly higher risks of bradyarrhythmia and permanent pacemaker implantation than matched controls. Among patients with HCM, atrial fibrillation increased the risks of both outcomes, while heart failure was associated with a higher risk of permanent pacemaker implantation.
Tsu‐An Yang +15 more
wiley +1 more source
Right Ventricular Sinus Myectomy to Facilitate Right Ventricle Growth
© 2021Pulmonary atresia with an intact ventricular septum (PAIVS) is a rare congenital cardiac disease with various structural abnormalities. For patients with moderate right ventricular (RV) hypoplasia for whom the decision has not been made between ...
Kim, Woong-Han +2 more
core +1 more source
Transaortic septal myectomy: techniques and pitfalls [PDF]
Hypertrophic cardiomyopathy (HCM) is the most common congenital cardiac disease, affecting up to 1 in 200 individuals. When it causes left ventricular outflow tract (LVOT) obstruction, treatment is indicated to reduce symptoms and the risk of sudden cardiac death. Pharmacologic therapy is the first line treatment, however if it fails, surgical myectomy
Anthony, Ralph-Edwards +2 more
openaire +2 more sources
ESC Heart Failure, Volume 12, Issue 2, Page 727-729, April 2025.
Wojciech Kosmala +1 more
wiley +1 more source
Although in silico tools predicted minimal splicing impact, functional minigene assays demonstrate that the synonymous MYH6 c.804G>C variant induces partial exon 10 skipping (~6.8% in HEK293T cells and ~4.7% in HeLa cells), supporting its potential contribution to HCM pathogenesis.
Songlin Zhang +5 more
wiley +1 more source
In this review article, we summarized the current status of EFTR for SETs and discussed future clinical applications for epithelial neoplasms from oncological and technical perspectives. EFTR is clinically feasible for treating gastric SETs. Future investigations and technical innovations are required to expand the clinical indications for EFTR in ...
Seiichiro Abe +11 more
wiley +1 more source
Minimally Invasive Septal Myectomy for Hypertrophic Obstructive Cardiomyopathy
Surgical septal myectomy is the treatment of choice for patients with symptomatic hypertrophic obstructive cardiomyopathy refractory to medications.
Ralph J. Damiano +3 more
core +1 more source
Functional blindness: Blepharospasm with apraxia of eyelid opening
Purpose: The purpose was to evaluate the effectiveness of protractor myectomy surgery in patients with severe blepharospasm whose daily life is severely impaired.
Titap Yazicioglu
doaj +1 more source
Surgical myectomy: Rationale and personalized technique
Septal myectomy is currently the gold standard treatment for symptomatic patients with hypertrophic cardiomyopathy. The procedure needs to be tailored and performed in a personalized fashion, taking into consideration the anatomical spectrum of this disease.The procedure needs to address the various components that contribute to the clinical and ...
Hamood Al Kindi, Magdi H. Yacoub
openaire +3 more sources
ABSTRACT This case describes a female infant with RAF1‐related Noonan syndrome who developed severe hypertrophic obstructive cardiomyopathy, pulmonary hypertension, and cardiorespiratory failure that responded to trametinib treatment but ultimately progressed to death following dose tapering and discontinuation of therapy. To the best of our knowledge,
C. Noah Nilsson +8 more
wiley +1 more source

